Rang	Name	Position
1	Mr. Robert Scott Goodman	CEO & Director
2	Mr. Daniel J. Moorhead CPA	Chief Financial Officer
3	Mr. Michael A. Gaul	Chief Operating Officer
4	Mr. Denton Drewell	Principal Accounting Officer & Controller
5	Dr. Andrew R. Colin M.D.	Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board
6	Dr. John Jett Ph.D.	Head of Research & Clinical Development
7	Mr. Amir Avniel	Chief Executive Officer of NeuroNOS
8	Mr. Adam T. Newman	Corporate Secretary

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Balyasny Asset Management LLC	3,07%	0,11 Mio. USD
2	Murchinson Ltd.	2,18%	0,08 Mio. USD
3	Geode Capital Management, LLC	1,06%	0,04 Mio. USD
4	Daytona Street Capital LLC	1,00%	0,04 Mio. USD
5	Bleichroeder LP	0,57%	0,02 Mio. USD
6	Vanguard Capital Management, LLC	0,21%	0,01 Mio. USD
7	Vanguard Fiduciary Trust Co	0,19%	0,01 Mio. USD
8	Jane Street Group LLC	0,18%	0,01 Mio. USD
9	BlackRock Inc	0,15%	0,01 Mio. USD
10	WEALTH EFFECTS LLC	0,11%	0,00 Mio. USD
11	Baldwin Brothers Inc	0,10%	0,00 Mio. USD
12	XTX Topco Ltd	0,08%	0,00 Mio. USD
13	Virtu Financial LLC	0,07%	0,00 Mio. USD
14	Advisor Group Holdings, Inc.	0,05%	0,00 Mio. USD
15	Tower Research Capital LLC	0,03%	0,00 Mio. USD
16	PFS Partners, LLC	0,01%	0,00 Mio. USD
17	IFP Advisors, LLC	0,01%	0,00 Mio. USD
18	Vanguard Global Advisers, LLC	0,00%	0,00 Mio. USD
19	Mccormack Advisors International	0,00%	0,00 Mio. USD
20	Goss Wealth Management LLC	0,00%	0,00 Mio. USD